Sector ratings Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
01:11:35 2026-08-31 pm EDT
|
5-day change | 1st Jan Change | ||
| 287.66 USD | -1.32% |
|
-3.69% | +44.15% |
| Aug. 20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| Aug. 20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 13.92B | AA | |||||||
| 50.47B | AAA | |||||||
| 44.56B | - | B | - | - | ||||
| 43.08B | AAA | |||||||
| 41.7B | - | |||||||
| 33.21B | A | |||||||
| 16.77B | BBB | |||||||
| 16.28B | - | - | - | - | ||||
| 14.58B | AA | |||||||
| 13.12B | AAA | |||||||
| 11.56B | A | - | ||||||
| 11.35B | AA | |||||||
| 10.96B | AA | |||||||
| 10.58B | - | BBB | - | - | ||||
| 10.18B | - | B | - | - | ||||
| 10.15B | - | A | - | - | ||||
| 9.82B | - | BBB | - | - | ||||
| 9.77B | AA | - | ||||||
| 9.63B | - | B | - | - | ||||
| 9.34B | BB | - | ||||||
| Average | 19.55B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
